Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laquinimod versus placebo with reference interferon beta-1a in relapsing-remitting multiple sclerosis
2007-005450-23Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of laquinimod in multiple sclerosis (MS) (3 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Number of confirmed relapses during the treatment period. Started Jan 2008; status: completed.
02
Drugs
laquinimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2007-005450-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005450-23.